Brain-Computer Interface Takes Center Stage at the 92nd CMEF: Medical Device Companies Showcase Innovation and Global Competitiveness

Source: Securities Daily

Reporter Wang Jingru from our newspaper

From September 26 to 29, the 92nd China International Medical Equipment Fair (CMEF) was held at the Guangzhou Pazhou Exhibition Center. The exhibition area of this session is nearly 160,000 square meters, attracting nearly 3,000 companies from nearly 20 countries and regions, and is expected to welcome more than 120,000 professional visitors.

As the "barometer" of the global medical industry, this year's CMEF not only gathers industrial clusters from regions such as Guangdong, Jiangsu, and Zhejiang in China, but also attracts delegations from 20 countries and regions including Germany, the United States, and Japan, showcasing the latest achievements and development trends in the field of medical devices.

Brain-Computer Interface Gains Significant Attention

In recent years, artificial intelligence has been accelerating its integration into medical services, with application scenarios continuously expanding from intelligent diagnosis to clinical decision-making and hospital management. In the center of the exhibition area, the brain-computer interface technology booth attracted a large crowd, with visitors eager to experience "mind control."

HenanSunnyou Medical"Brain-Controlled Upper and Lower Limb Active-Passive Rehabilitation System" Launched by Xiangyu Medical Co., Ltd. (hereinafter referred to as "Sunnyou") Draws Attention. Patients only need to wear a lightweight headband to achieve millisecond-level decoding of brain electrical signals, accurately matching movement intentions and driving the device for rehabilitation training. "Our company initiated brain-computer interface research and development in 2015 and established a brain science laboratory in 2024. We are currently actively building a 'brain-computer interface + rehabilitation' industrial ecosystem, covering the entire rehabilitation chain for patients," a Sunnyou staff member told the Securities Daily.

SHAONAO-TECH showcased a full-scenario solution for "EEG acquisition + brain-controlled interaction," which can drive execution devices to complete rehabilitation training through EEG acquisition, signal processing, and intention decoding. Currently, the company's EEG-based rehabilitation training equipment has obtained the medical device registration certificate for brain-computer interfaces in Shanghai.

At the policy level, momentum has been injected into this emerging industry. In July 2025, the Ministry of Industry and Information Technology and six other departments issued the "Implementation Opinions on Promoting the Innovative Development of the Brain-Computer Interface Industry," proposing that by 2027, breakthroughs will be made in key brain-computer interface technologies, and advanced technology, industrial, and standard systems will be initially established. The performance of electrodes, chips, and complete machines will reach international advanced levels, and brain-computer interface products will accelerate their application in fields such as industrial manufacturing, healthcare, and consumer living. The scale of the industry will continue to grow, creating 2 to 3 industrial development clusters and opening up a range of new scenarios, models, and business formats.

"Brain-computer interfaces have moved from the laboratory to clinical application scenarios, and are expected to play a significant role in rehabilitation medicine, neuromodulation, and aging health management," said Zhang Xiaorong, dean of the Deep Technology Research Institute, in an interview with *Securities Daily*. "As the technology matures and costs decrease, brain-computer interfaces will bring new growth points to the medical device industry."

At the same time, domestic companies are also leveraging AI to fill technological gaps. AccuMedTech (Beijing) Co., Ltd. (hereinafter referred to as "AccuMedTech"), incubated by Beijing Institute of Technology, specializes in surgical technologies.RobotUpstream Enterprises: Debut of Ruitong SE 3D, a New Optical Positioning Product. Based on binocular structured light technology, this product achieves 25 frames per second 3D reconstruction and sub-millimeter accuracy with a compact body. It also integrates "real-time reconstruction + markerless tracking" functions, suitable for neurosurgical navigation, transcranial magnetic stimulation positioning, rehabilitation training assessment, and other scenarios.

"Our company's technology is entirely self-developed, breaking the foreign monopoly. It has currently been put into use in hospitals and is gradually achieving domestic substitution," said a staff member of RealMed to the *Securities Daily*.

Opportunities in Overseas Markets Highlighted

In addition to showcasing technological innovation achievements, CMEF has also become an important window for Chinese medical device companies to "go global."

The organizer revealed that this exhibition has attracted buyers from more than 130 countries and regions. Purchase demands have been received from countries such as Bangladesh, Israel, Germany, Colombia, and Australia, covering multiple fields including medical consumables, diagnostic reagents, imaging equipment, endoscopes, and molecular diagnostics. The purchase amounts range from tens of thousands to millions of US dollars.

Staff from Jiangxi Hongda Medical Device Group Co., Ltd. stated: "In addition to focusing on the compatibility of products with international standards and certification qualifications, foreign customers also pay close attention to overseas supply chain security and after-sales service systems during consultations."

In recent years, Southeast Asia has become an important destination for Chinese medical device companies to "go overseas." According to the organizer, the proportion of Southeast Asian buyers in the international procurement demand collected at this exhibition has increased significantly. Countries such as Vietnam and Thailand have a strong demand for basic medical equipment and consumables, and interest in high-end products such as molecular diagnostics and imaging equipment is also growing in some countries.

A staff member responsible for the expansion of the Southeast Asian market told the Securities Daily reporter: "In the past, medical devices in the local market mainly came from Europe, but products from Chinese companies have both price and quality advantages, especially in imaging and testing reagents, their competitiveness is becoming stronger and stronger."

    CSC FinancialSecurities research reports show that over the past 20 years, the product strength of China's medical device companies has continuously improved. Relying on excellent product strength, overseas localization operations, and factory construction, several enterprises have achieved rapid growth in overseas business and built up global competitiveness.

It is foreseeable that, with continuous technological breakthroughs and the gradual improvement of the standards system, China's medical device industry will embrace broader development opportunities in the waves of digitalization, intelligence, and globalization.